Azimuth Capital Investment Management LLC boosted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 23.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,783 shares of the pharmaceutical company’s stock after purchasing an additional 8,353 shares […]
Allstate Investment Management Co. bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 12,636 shares of the pharmaceutical company’s stock, valued at approximately $3,649,000. Other institutional investors and hedge […]
Davis Investment Partners LLC bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 4,230 shares of the pharmaceutical company’s stock, valued at approximately $1,266,000. Vertex Pharmaceuticals comprises approximately 0.6% of […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Rating) had its price target hoisted by Royal Bank of Canada from $315.00 to $323.00 in a research report sent to investors on Thursday, The Fly reports. Other analysts have also issued reports about the stock. SVB Securities lowered their price objective on shares of Vertex Pharmaceuticals from $374.00 to […]
Amundi increased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 16.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,130,197 shares of the pharmaceutical company’s stock after acquiring an additional 304,875 shares during the period. Amundi’s holdings […]